Scarica l'app Stockscreener
95.29
0.09%
-0.09
Dopo l'orario di chiusura:
95.50
0.21
+0.22%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché CVS Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$95.38
Aprire:
$96.01
Volume 24 ore:
3.86M
Relative Volume:
0.51
Capitalizzazione di mercato:
$121.87B
Reddito:
$407.94B
Utile/perdita netta:
$2.90B
Rapporto P/E:
41.85
EPS:
2.2771
Flusso di cassa netto:
$7.39B
1 W Prestazione:
-1.97%
1M Prestazione:
-0.40%
6M Prestazione:
+24.86%
1 anno Prestazione:
+28.82%
Intervallo 1D:
$94.88
$97.32
Intervallo di 1 settimana:
$92.79
$97.98
Portata 52W:
$69.51
$110.68
Cvs Health Corp Stock (CVS) Company Profile
Nome
Cvs Health Corp
Settore
Industria
Telefono
(401) 765-1500
Indirizzo
ONE CVS DR., WOONSOCKET
Compare CVS vs UNH, ELV, CI, HUM
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CVS
Cvs Health Corp
|
95.29 | 121.99B | 407.94B | 2.90B | 7.39B | 2.2771 |
UNH
Unitedhealth Group Inc
|
388.28 | 352.81B | 450.13B | 14.91B | 23.62B | 15.55 |
ELV
Elevance Health Inc
|
416.54 | 86.08B | 201.11B | 4.95B | 6.29B | 22.50 |
CI
Cigna Group
|
280.91 | 73.50B | 278.13B | 6.74B | 7.66B | 23.60 |
HUM
Humana Inc
|
400.73 | 48.03B | 137.20B | 1.15B | 1.27B | 9.3439 |
Cvs Health Corp Stock (CVS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-03-12 | Aggiornamento | Bernstein | Mkt Perform → Outperform |
| 2025-10-14 | Iniziato | Goldman | Buy |
| 2025-08-18 | Aggiornamento | UBS | Neutral → Buy |
| 2025-08-14 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2025-02-13 | Aggiornamento | Leerink Partners | Market Perform → Outperform |
| 2025-02-12 | Aggiornamento | Cantor Fitzgerald | Neutral → Overweight |
| 2025-01-30 | Aggiornamento | Edward Jones | Hold → Buy |
| 2024-12-03 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2024-11-18 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2024-10-10 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2024-10-04 | Aggiornamento | TD Cowen | Hold → Buy |
| 2024-05-30 | Iniziato | Robert W. Baird | Neutral |
| 2024-05-07 | Downgrade | TD Cowen | Buy → Hold |
| 2024-05-02 | Downgrade | UBS | Buy → Neutral |
| 2024-05-01 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2024-05-01 | Downgrade | Leerink Partners | Outperform → Market Perform |
| 2024-03-06 | Iniziato | Barclays | Equal Weight |
| 2024-02-26 | Iniziato | Leerink Partners | Outperform |
| 2023-12-22 | Iniziato | HSBC Securities | Buy |
| 2023-09-19 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2023-09-12 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2023-08-18 | Downgrade | Edward Jones | Buy → Hold |
| 2023-05-26 | Iniziato | Piper Sandler | Overweight |
| 2023-04-21 | Iniziato | Cantor Fitzgerald | Overweight |
| 2023-01-03 | Downgrade | Evercore ISI | Outperform → In-line |
| 2022-11-23 | Ripresa | Morgan Stanley | Overweight |
| 2022-06-17 | Iniziato | Loop Capital | Buy |
| 2022-05-27 | Downgrade | Bernstein | Outperform → Mkt Perform |
| 2022-03-29 | Downgrade | Deutsche Bank | Buy → Hold |
| 2022-02-11 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2021-12-14 | Iniziato | Goldman | Buy |
| 2021-12-01 | Iniziato | Seaport Research Partners | Buy |
| 2021-05-19 | Iniziato | Wells Fargo | Equal Weight |
| 2021-03-17 | Downgrade | Guggenheim | Buy → Neutral |
| 2021-01-08 | Aggiornamento | Jefferies | Hold → Buy |
| 2020-09-17 | Iniziato | Piper Sandler | Overweight |
| 2020-07-01 | Iniziato | SVB Leerink | Mkt Perform |
| 2020-05-14 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2019-09-27 | Ripresa | RBC Capital Mkts | Outperform |
| 2019-09-12 | Iniziato | Deutsche Bank | Buy |
| 2019-06-05 | Aggiornamento | Standpoint Research | Hold → Buy |
| 2019-04-29 | Downgrade | Credit Suisse | Outperform → Neutral |
| 2019-04-18 | Iniziato | Guggenheim | Buy |
| 2019-04-15 | Downgrade | Oppenheimer | Outperform → Perform |
| 2019-04-10 | Reiterato | BofA/Merrill | Buy |
| 2019-03-13 | Iniziato | Bernstein | Outperform |
| 2019-02-20 | Downgrade | Wells Fargo | Outperform → Market Perform |
| 2019-01-17 | Iniziato | UBS | Buy |
| 2018-12-18 | Iniziato | Barclays | Overweight |
| 2018-11-29 | Ripresa | Goldman | Neutral |
| 2018-11-28 | Iniziato | Evercore ISI | Outperform |
| 2018-10-26 | Ripresa | Wolfe Research | Peer Perform |
| 2018-07-09 | Aggiornamento | Citigroup | Neutral → Buy |
| 2018-02-27 | Ripresa | BofA/Merrill | Buy |
| 2018-02-13 | Reiterato | Citigroup | Neutral |
Mostra tutto
Cvs Health Corp Borsa (CVS) Ultime notizie
CVS Health stock heads into the open after a modest September 10 gain - ad-hoc-news.de
Is CVS Health (CVS) Still Undervalued After Its Wells Fargo Healthcare Conference Update? - simplywall.st
CVS Health stock holds gains after UBS cuts target - ad-hoc-news.de
Should You Buy, Hold or Sell CVS Stock Amid Consumer Wellness Growth? - Yahoo Finance
Updated COVID-19 Vaccines Available at CVS Pharmacy and MinuteClinic Across the U.S. - csrwire.com
CVS Health redevelops soccer pitch alongside Seattle Reign FC and the RAVE Foundation - CVS Health
CVS Health: Buy The Pullback Before Earnings Power Ramps Up (NYSE:CVS) - Seeking Alpha
National Pension Service Trims Stock Holdings in CVS Health Corporation $CVS - MarketBeat
CVS Health Eyes Margin Recovery, Cash Flow as 2027 Headwinds Loom - MarketBeat
CVS Health flags elevated medical expenses, sending managed care lower - Seeking Alpha
Trump Administration May Be Letting Pharmacy Benefit Managers Off Easy - Yahoo Finance
CVS Health at Wells Fargo healthcare conference: turnaround gains traction By Investing.com - Investing.com Canada
CVS Health at Wells Fargo healthcare conference: turnaround gains traction - Investing.com
Bernstein raises CVS Health stock price target on faster Aetna turnaround - Investing.com
CVS Health Corporation at Wells Fargo Healthcare Conference Transcript - GuruFocus
CVS Health marks 20 years of Project Health free screenings - CVS Health
CVS Health Corporation (CVS) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance
CVS Health Corp. stock gains on strong Q2 2026 earnings beat - ad-hoc-news.de
Wall Street Loves CVS Health Stock Right Now. Should You? - Yahoo Finance
CVS Health (CVS) Launches Updated 2026 2027 COVID 19 Vaccines Nationwide - simplywall.st
Back-to-School Health Checklist: What Parents Can Do To Help Kids Start the School Year Strong - ACCESS Newswire
What Is Putting CVS Health Stock in Focus? (NYSE:CVS) - Kalkine Media
What Women Want From Weight Management Support, and Why It Matters - ACCESS Newswire
News by ACCESS Newswire on TradingView, 2026-09-08 - TradingView
CVS Health Corp stock gains as margin repair at Aetna boosts outlook - ad-hoc-news.de
Groupe la Francaise Takes $5.17 Million Position in CVS Health Corporation $CVS - MarketBeat
California State Teachers Retirement System Has $20 Billion Stock Holdings in CVS Health Corporation $CVS - MarketBeat
CVS Health Corporation $CVS Shares Sold by Continuum Advisory LLC - MarketBeat
CVS Health Corp stock holds steady as investors digest strong earnings and outlook - ad-hoc-news.de
Here's How CVS Is Focusing on Aetna's Profitability Turnaround - Yahoo Finance
CVS Health Corporation $CVS Shares Purchased by Amundi - MarketBeat
Living With Primary Immunodeficiency: How Specialty Care Supports Nick's Journey - ACCESS Newswire
CVS Health signs on as official partner of professional volleyball league - Providence Business News
CVS Health (CVS) Stock Looks Below Fair Value But Mixed After 65% Return - Yahoo Finance
Saudi Central Bank Buys 42,199 Shares of CVS Health Corporation $CVS - MarketBeat
CVS Health stock gains as vaccines and Q2 beat support it - ad-hoc-news.de
Azimuth Capital Investment Management LLC Raises Stock Position in CVS Health Corporation $CVS - MarketBeat
Jim Cramer Says “Own It, Don’t Trade It” as CVS Health Gains Momentum - Yahoo Finance
Munich Reinsurance Co Stock Corp in Munich Takes $47.53 Million Position in CVS Health Corporation $CVS - MarketBeat
NEOS Investment Management LLC Raises Holdings in CVS Health Corporation $CVS - MarketBeat
Concurrent Investment Advisors LLC Grows Stake in CVS Health Corporation $CVS - MarketBeat
CVS Health (CVS) Up 1% Since Last Earnings Report: Can It Continue? - Yahoo Finance
Is CVS Health Outperforming the Nasdaq? - Yahoo Finance
TD Waterhouse Canada Inc. Increases Stake in CVS Health Corporation $CVS - MarketBeat
CVS Escapes Customer's Generic Mucinex Benzene Suit - Law360
Why Is CVS Health (NYSE:CVS) Drawing Fresh Attention in Value Stocks? - Kalkine Media
CVS Health Corp. stock gains on UBS buy rating and raised revenue outlook - ad-hoc-news.de
Updated COVID-19 vaccines available at CVS Pharmacy and MinuteClinic across the U.S. - CVS Health
Most insured patients can get updated COVID vaccines at CVS for no cost - Stock Titan
Mapping vertical integration in US health insurance - brookings.edu
CVS Health Corp (N: CVS) Share Price, CVS Stock News, CVS Share Price & Updates - Kalkine
Cvs Health Corp Azioni (CVS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
4.95%
1.74%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):